VHL — Vitasora Health Income Statement
0.000.00%
Last trade - 00:00- AU$42.58m
- AU$42.24m
- AU$3.71m
Annual income statement for Vitasora Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.44 | 0.779 | 0.662 | 1.04 | 3.71 |
| Cost of Revenue | |||||
| Gross Profit | 0.174 | 0.52 | 0.597 | 1.03 | 3.68 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 12.4 | 7.33 | 6.42 | 8.09 | 13.8 |
| Operating Profit | -11 | -6.55 | -5.75 | -7.05 | -10.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -11 | -6.62 | -5.78 | -7.13 | -10.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11 | -6.62 | -5.78 | -7.13 | -10.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11 | -6.62 | -5.78 | -7.13 | -10.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11 | -6.62 | -5.78 | -7.13 | -10.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.016 | -0.009 | -0.007 | -0.007 | -0.007 |